Joint/commissioned bioequivalence testing policy has pros and cons

Published: 2010-08-11 06:59:00
Updated: 2010-08-11 06:59:00
Some pharmaceutical companies are eagerly pursuing the independent conduct of bioequivalence testing to improve their global competitiveness.

But other companies said the controversial joint and/or commissioned bioequivalence testing system should exist to ensure less cost and quality in a col...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.